Cargando…
Overexpression of Canonical Prefoldin Associates with the Risk of Mortality and Metastasis in Non-Small Cell Lung Cancer
Canonical prefoldin is a protein cochaperone composed of six different subunits (PFDN1 to 6). PFDN1 overexpression promotes epithelial–mesenchymal transition (EMT) and increases the growth of xenograft lung cancer (LC) cell lines. We investigated whether this putative involvement of canonical PFDN i...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225921/ https://www.ncbi.nlm.nih.gov/pubmed/32344577 http://dx.doi.org/10.3390/cancers12041052 |
_version_ | 1783534165975629824 |
---|---|
author | Peñate, Xenia Praena-Fernández, Juan Manuel Romero Pareja, Pedro Enguix-Riego, María del Valle Payán-Bravo, Laura Vieites, Begoña Gomez-Izquierdo, Lourdes Jaen Olasolo, Javier Rivin del Campo, Eleonor Reyes, Jose Carlos Chávez, Sebastián Lopez Guerra, Jose Luis |
author_facet | Peñate, Xenia Praena-Fernández, Juan Manuel Romero Pareja, Pedro Enguix-Riego, María del Valle Payán-Bravo, Laura Vieites, Begoña Gomez-Izquierdo, Lourdes Jaen Olasolo, Javier Rivin del Campo, Eleonor Reyes, Jose Carlos Chávez, Sebastián Lopez Guerra, Jose Luis |
author_sort | Peñate, Xenia |
collection | PubMed |
description | Canonical prefoldin is a protein cochaperone composed of six different subunits (PFDN1 to 6). PFDN1 overexpression promotes epithelial–mesenchymal transition (EMT) and increases the growth of xenograft lung cancer (LC) cell lines. We investigated whether this putative involvement of canonical PFDN in LC translates into the clinic. First, the mRNA expression of 518 non-small cell LC (NSCLC) cases from The Cancer Genome Atlas (TCGA) database was evaluated. Patients with PFDN1 overexpression had lower overall survival (OS; 45 vs. 86 months; p = 0.034). We then assessed the impact of PFDN expression on outcome in 58 NSCLC patients with available tumor tissue samples. PFDN1, 3, and 5 overexpression were found in 38% (n = 22), 53% (n = 31), and 41% (n = 24) of tumor samples. PFDN1, 3, and 5 overexpression were significantly associated with lower OS, lower disease-free survival (DFS), and lower distant metastasis-free survival (DMFS) for PFDN1 and 3 with a trend for PFDN5. In multivariate analysis, PFDN5 retained significance for OS (hazard ratio (HR) 2.56; p = 0.007) and PFDN1 for DFS (HR 2.53; p = 0.010) and marginally for DMFS (HR 2.32; p = 0.053). Our results indicate that protein response markers, such as PFDN1, 3, and 5, may complement mRNA signatures and be useful for determining the most appropriate therapy for NSCLC patients. |
format | Online Article Text |
id | pubmed-7225921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72259212020-05-18 Overexpression of Canonical Prefoldin Associates with the Risk of Mortality and Metastasis in Non-Small Cell Lung Cancer Peñate, Xenia Praena-Fernández, Juan Manuel Romero Pareja, Pedro Enguix-Riego, María del Valle Payán-Bravo, Laura Vieites, Begoña Gomez-Izquierdo, Lourdes Jaen Olasolo, Javier Rivin del Campo, Eleonor Reyes, Jose Carlos Chávez, Sebastián Lopez Guerra, Jose Luis Cancers (Basel) Brief Report Canonical prefoldin is a protein cochaperone composed of six different subunits (PFDN1 to 6). PFDN1 overexpression promotes epithelial–mesenchymal transition (EMT) and increases the growth of xenograft lung cancer (LC) cell lines. We investigated whether this putative involvement of canonical PFDN in LC translates into the clinic. First, the mRNA expression of 518 non-small cell LC (NSCLC) cases from The Cancer Genome Atlas (TCGA) database was evaluated. Patients with PFDN1 overexpression had lower overall survival (OS; 45 vs. 86 months; p = 0.034). We then assessed the impact of PFDN expression on outcome in 58 NSCLC patients with available tumor tissue samples. PFDN1, 3, and 5 overexpression were found in 38% (n = 22), 53% (n = 31), and 41% (n = 24) of tumor samples. PFDN1, 3, and 5 overexpression were significantly associated with lower OS, lower disease-free survival (DFS), and lower distant metastasis-free survival (DMFS) for PFDN1 and 3 with a trend for PFDN5. In multivariate analysis, PFDN5 retained significance for OS (hazard ratio (HR) 2.56; p = 0.007) and PFDN1 for DFS (HR 2.53; p = 0.010) and marginally for DMFS (HR 2.32; p = 0.053). Our results indicate that protein response markers, such as PFDN1, 3, and 5, may complement mRNA signatures and be useful for determining the most appropriate therapy for NSCLC patients. MDPI 2020-04-24 /pmc/articles/PMC7225921/ /pubmed/32344577 http://dx.doi.org/10.3390/cancers12041052 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Peñate, Xenia Praena-Fernández, Juan Manuel Romero Pareja, Pedro Enguix-Riego, María del Valle Payán-Bravo, Laura Vieites, Begoña Gomez-Izquierdo, Lourdes Jaen Olasolo, Javier Rivin del Campo, Eleonor Reyes, Jose Carlos Chávez, Sebastián Lopez Guerra, Jose Luis Overexpression of Canonical Prefoldin Associates with the Risk of Mortality and Metastasis in Non-Small Cell Lung Cancer |
title | Overexpression of Canonical Prefoldin Associates with the Risk of Mortality and Metastasis in Non-Small Cell Lung Cancer |
title_full | Overexpression of Canonical Prefoldin Associates with the Risk of Mortality and Metastasis in Non-Small Cell Lung Cancer |
title_fullStr | Overexpression of Canonical Prefoldin Associates with the Risk of Mortality and Metastasis in Non-Small Cell Lung Cancer |
title_full_unstemmed | Overexpression of Canonical Prefoldin Associates with the Risk of Mortality and Metastasis in Non-Small Cell Lung Cancer |
title_short | Overexpression of Canonical Prefoldin Associates with the Risk of Mortality and Metastasis in Non-Small Cell Lung Cancer |
title_sort | overexpression of canonical prefoldin associates with the risk of mortality and metastasis in non-small cell lung cancer |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225921/ https://www.ncbi.nlm.nih.gov/pubmed/32344577 http://dx.doi.org/10.3390/cancers12041052 |
work_keys_str_mv | AT penatexenia overexpressionofcanonicalprefoldinassociateswiththeriskofmortalityandmetastasisinnonsmallcelllungcancer AT praenafernandezjuanmanuel overexpressionofcanonicalprefoldinassociateswiththeriskofmortalityandmetastasisinnonsmallcelllungcancer AT romeroparejapedro overexpressionofcanonicalprefoldinassociateswiththeriskofmortalityandmetastasisinnonsmallcelllungcancer AT enguixriegomariadelvalle overexpressionofcanonicalprefoldinassociateswiththeriskofmortalityandmetastasisinnonsmallcelllungcancer AT payanbravolaura overexpressionofcanonicalprefoldinassociateswiththeriskofmortalityandmetastasisinnonsmallcelllungcancer AT vieitesbegona overexpressionofcanonicalprefoldinassociateswiththeriskofmortalityandmetastasisinnonsmallcelllungcancer AT gomezizquierdolourdes overexpressionofcanonicalprefoldinassociateswiththeriskofmortalityandmetastasisinnonsmallcelllungcancer AT jaenolasolojavier overexpressionofcanonicalprefoldinassociateswiththeriskofmortalityandmetastasisinnonsmallcelllungcancer AT rivindelcampoeleonor overexpressionofcanonicalprefoldinassociateswiththeriskofmortalityandmetastasisinnonsmallcelllungcancer AT reyesjosecarlos overexpressionofcanonicalprefoldinassociateswiththeriskofmortalityandmetastasisinnonsmallcelllungcancer AT chavezsebastian overexpressionofcanonicalprefoldinassociateswiththeriskofmortalityandmetastasisinnonsmallcelllungcancer AT lopezguerrajoseluis overexpressionofcanonicalprefoldinassociateswiththeriskofmortalityandmetastasisinnonsmallcelllungcancer |